| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,349 |
1,160 |
$78K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
946 |
861 |
$61K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
964 |
822 |
$37K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
928 |
740 |
$34K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
695 |
574 |
$25K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
488 |
429 |
$22K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
157 |
140 |
$13K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
111 |
101 |
$11K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
186 |
147 |
$1K |
| 81002 |
|
386 |
358 |
$786.60 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
74 |
70 |
$637.63 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
52 |
48 |
$523.50 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
36 |
30 |
$387.25 |
| 99000 |
|
76 |
71 |
$206.37 |
| 36415 |
Collection of venous blood by venipuncture |
73 |
68 |
$184.44 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
37 |
36 |
$179.55 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
19 |
14 |
$23.97 |